HomeLYEL • NASDAQ
add
Lyell Immunopharma Inc
Previous close
$25.25
Day range
$25.51 - $28.86
Year range
$7.65 - $28.86
Market cap
601.75M USD
Avg Volume
36.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 15.00K | -55.88% |
Operating expense | 37.27M | -26.26% |
Net income | -38.85M | 12.87% |
Net profit margin | -258.97K | -97.50% |
Earnings per share | — | — |
EBITDA | -34.69M | 24.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 319.62M | -27.45% |
Total assets | 407.96M | -34.12% |
Total liabilities | 78.84M | -10.93% |
Total equity | 329.12M | — |
Shares outstanding | 21.22M | — |
Price to book | 1.48 | — |
Return on assets | -23.48% | — |
Return on capital | -25.61% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -38.85M | 12.87% |
Cash from operations | -28.58M | 18.45% |
Cash from investing | 3.35M | 74.61% |
Cash from financing | 50.00M | — |
Net change in cash | 24.77M | 174.79% |
Free cash flow | -15.22M | 14.13% |
About
Founded
2018
Headquarters
Website
Employees
300
